Crea il mio profilo
Accesso pubblico
Visualizza tutto16 articoli
0 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Silvia BuonamiciConsultant Third Rock VenturesEmail verificata su thirdrockventures.com
- Shridar GanesanProfessor of Medicine, Rutgers Cancer Institute of New JerseyEmail verificata su cinj.rutgers.edu
- Anupama ReddyData Scientist | Co-founder @ Vindhya Data ScienceEmail verificata su vindhyadatascience.com
- Anant Akash AgrawalRemix TherapeuticsEmail verificata su remixtx.com
- James PalacinoHead of Biology, Orum TherapeuticsEmail verificata su orumrx.com
- Benjamin L. EbertDana-Farber Cancer InstituteEmail verificata su dfci.harvard.edu
- Peter Fekkes54gene, HotSpot Therapeutics, H3 Biomedicine, Novartis, UC San Diego, University of GroningenEmail verificata su 54gene.com
- George VassiliouProfessor of Haematological Medicine, University of Cambridge & Cambridge Stem Cell InstituteEmail verificata su sanger.ac.uk
- Frederic VaillancourtSVP, Head of Early Research, Remix TherapeuticsEmail verificata su remixtx.com
- Annalisa MupoScientific Programme ManagerEmail verificata su altoslabs.com
- Chia-Ling HuangNovartis Institutes of Biomedical ResearchEmail verificata su bu.edu
- Jinesh GheeyaThe Ohio State UniversityEmail verificata su osumc.edu
- Peter SmithUniversity of SunderlandEmail verificata su sunderland.ac.uk
- Zuzana TothovaDana-Farber Cancer Institute, Broad InstituteEmail verificata su broadinstitute.org
- Katsuhiro TogamiMedical oncology, Dana-Farbar Cancer InstitutionEmail verificata su dfci.harvard.edu
- Andrew A. Lane, MD, PhDDana-Farber Cancer InstituteEmail verificata su dfci.harvard.edu
- Stanley Chun-Wei LeeFred Hutchinson Cancer CenterEmail verificata su fredhutch.org
- Bryan M. DunyakRemix TherapeuticsEmail verificata su remixtx.com
- Jesper L.V. MaagRemix TherapeuticsEmail verificata su remixtx.com